Clinical Trial Update: SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries [Phase 3]

View source ↗

Summary

This is a Phase 3 trial update of the SYNTAX study comparing the Taxus paclitaxel-eluting stent with coronary artery bypass surgery for coronary artery disease,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Taxus Drug-Eluting Stent (paclitaxel-eluting stent)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | Phase 3 | Status: UNKNOWN | Results posted: 2010-06-23